An Asia Hub: Novartis Plans Biotech Manufacturing Center In Singapore
This article was originally published in PharmAsia News
Executive Summary
Novartis plans to build a new center of excellence for biotechnology manufacturing costing more than $500 million, as it looks to leverage Singapore’s skilled labor force and proximity to growth markets like China.